AUD 0.02
(N/A%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 5.5 Million AUD | -26.31% |
2023 | 7.47 Million AUD | -26.64% |
2022 | 10.18 Million AUD | -5.74% |
2021 | 10.8 Million AUD | 11.98% |
2020 | 9.65 Million AUD | 12.15% |
2019 | 8.6 Million AUD | 22.96% |
2018 | 7 Million AUD | -22.88% |
2017 | 9.07 Million AUD | -11.49% |
2016 | 10.25 Million AUD | 15.35% |
2015 | 8.89 Million AUD | 0.07% |
2014 | 8.88 Million AUD | 50.4% |
2013 | 5.9 Million AUD | -2.67% |
2012 | 6.06 Million AUD | -4.49% |
2011 | 6.35 Million AUD | -1.85% |
2010 | 6.47 Million AUD | -1.91% |
2009 | 6.6 Million AUD | -1.48% |
2008 | 6.69 Million AUD | 48.22% |
2007 | 4.51 Million AUD | 0.0% |
2005 | 215.69 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 FY | 5.5 Million AUD | -26.31% |
2024 Q4 | 5.5 Million AUD | 0.0% |
2024 Q2 | 5.57 Million AUD | 0.0% |
2023 Q2 | 9.71 Million AUD | 0.0% |
2023 FY | 7.47 Million AUD | -26.64% |
2023 Q4 | 7.47 Million AUD | 0.0% |
2022 Q4 | 10.18 Million AUD | 0.0% |
2022 FY | 10.18 Million AUD | -5.74% |
2022 Q2 | 11.3 Million AUD | 0.0% |
2021 Q4 | 10.8 Million AUD | 0.0% |
2021 FY | 10.8 Million AUD | 11.98% |
2021 Q2 | 8.78 Million AUD | 0.0% |
2020 Q4 | 9.65 Million AUD | 0.0% |
2020 FY | 9.65 Million AUD | 12.15% |
2020 Q2 | 8.46 Million AUD | 0.0% |
2019 FY | 8.6 Million AUD | 22.96% |
2019 Q2 | 780 Thousand AUD | 0.0% |
2019 Q4 | 8.6 Million AUD | 0.0% |
2018 Q4 | 7 Million AUD | 0.0% |
2018 Q2 | 2.27 Million AUD | 0.0% |
2018 FY | 7 Million AUD | -22.88% |
2017 Q2 | 1.85 Million AUD | 0.0% |
2017 FY | 9.07 Million AUD | -11.49% |
2017 Q4 | 9.07 Million AUD | 0.0% |
2016 Q4 | 10.25 Million AUD | 0.0% |
2016 Q2 | 1.81 Million AUD | 0.0% |
2016 FY | 10.25 Million AUD | 15.35% |
2015 Q4 | 8.89 Million AUD | 0.0% |
2015 FY | 8.89 Million AUD | 0.07% |
2015 Q2 | 904 Thousand AUD | 0.0% |
2014 Q2 | 1.42 Million AUD | 0.0% |
2014 FY | 8.88 Million AUD | 50.4% |
2014 Q4 | 8.88 Million AUD | 0.0% |
2013 Q2 | 6.11 Million AUD | 0.0% |
2013 Q4 | 5.9 Million AUD | 0.0% |
2013 FY | 5.9 Million AUD | -2.67% |
2012 FY | 6.06 Million AUD | -4.49% |
2012 Q4 | 6.06 Million AUD | 0.0% |
2011 FY | 6.35 Million AUD | -1.85% |
2011 Q4 | 6.35 Million AUD | 0.0% |
2010 Q4 | 6.47 Million AUD | 0.0% |
2010 FY | 6.47 Million AUD | -1.91% |
2009 FY | 6.6 Million AUD | -1.48% |
2009 Q4 | 6.6 Million AUD | 0.0% |
2008 FY | 6.69 Million AUD | 48.22% |
2008 Q4 | 6.69 Million AUD | 0.0% |
2007 FY | 4.51 Million AUD | 0.0% |
2007 Q4 | 4.51 Million AUD | 0.0% |
2005 FY | 215.69 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
4DMedical Limited | 49.08 Million AUD | 88.78% |
Adherium Limited | 3.4 Million AUD | -61.679% |
Aroa Biosurgery Limited | 14.77 Million AUD | 62.73% |
Atomo Diagnostics Limited | 1.29 Million AUD | -325.528% |
Anteris Technologies Ltd | 17.03 Million AUD | 67.674% |
Control Bionics Limited | 2.75 Million AUD | -99.594% |
CardieX Limited | 8.56 Million AUD | 35.672% |
Compumedics Limited | 22.14 Million AUD | 75.131% |
Cochlear Limited | 904.6 Million AUD | 99.391% |
CleanSpace Holdings Limited | 6.94 Million AUD | 20.745% |
Cyclopharm Limited | 13.65 Million AUD | 59.662% |
EMVision Medical Devices Ltd | 5.45 Million AUD | -0.959% |
Nova Eye Medical Limited | 8.55 Million AUD | 35.594% |
HeraMED Limited | 1.5 Million AUD | -265.752% |
Imricor Medical Systems, Inc. | 25 Million AUD | 77.972% |
ImpediMed Limited | 6.24 Million AUD | 11.773% |
InhaleRx Limited | 911.41 Thousand AUD | -504.336% |
Micro-X Limited | 12.63 Million AUD | 56.403% |
Neurotech International Limited | 314.69 Thousand AUD | -1650.244% |
OncoSil Medical Limited | 1.98 Million AUD | -177.902% |
PolyNovo Limited | 37.04 Million AUD | 85.131% |
Respiri Limited | 3.55 Million AUD | -54.981% |
SomnoMed Limited | 24.78 Million AUD | 77.773% |
Universal Biosensors, Inc. | 10.61 Million AUD | 48.099% |
Uscom Limited | 2.07 Million AUD | -165.628% |
Visioneering Technologies, Inc. | 2.76 Million AUD | -99.067% |